TRU-SENTIMENT · DeltaNeutral
BDX Trading Analysis - 11/06/2026 02:37 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
BDX (Becton Dickinson and Co.) at $212.23. True Sentiment Bullish, delta 40-60 call 89% / put 11%, call $736,550 vs put $88,690. RSI 80.0.
- Symbol
- BDX
- Price
- $212.23
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-11-06 14:37:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow is Bullish. Call dollar volume $736,550.00 (89.3%) vs put $88,690.00 (10.7%). Call contracts 543, put 207; call trades 10, put trades 2. Total analyzed 534, true sentiment 12 (2.2% filter).
Conviction: Strong directional call buying. Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" with advice to wait for alignment, yet technicals show clear bullish alignment and overbought RSI — divergence is in system interpretation, not raw data.
Key Statistics: BDX
Fundamental Snapshot
Valuation
| P/E (trailing) | 63.00 |
| EPS (trailing 12 mo) | $3.32 |
| Market cap | $57.76B |
| Shares outstanding | 272.4M |
Dividend
| Dividend yield | 2.01% |
| Annual dividend | $4.20 |
| Ex-dividend date | 2026-09-09 |
Risk & range
| Beta | -0.17 |
| 52-week low | $140.11 |
| 52-week high | $214.78 |
| Historical volatility | 25.6% |
Ownership & trading
| Institutional ownership | 70.7% |
| Average daily volume | 1.8M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
Becton Dickinson (BDX) recently reported fiscal full-year results with steady medical device demand, though supply-chain normalization remained a theme across the healthcare sector.
BDX confirmed a quarterly dividend of $1.05 per share (ex-dividend date 2026-09-09), reinforcing its defensive income profile amid macro uncertainty.
Industry headlines have highlighted hospital capital expenditure recovery, a potential tailwind for BDX's instrumentation and diagnostics segments.
No major negative regulatory actions or product recalls were broadly reported in the recent period; however, elevated valuation in med-tech has drawn caution from some commentators.
Context: The bullish options flow and sharp November price surge contrast with a traditionally low-beta defensive profile, suggesting a sentiment-driven move rather than a fundamental catalyst shift.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data:
- Trailing P/E: 63.00; Trailing EPS: $3.32
- Market Cap: $57,759,663,350.00; Shares Outstanding: 272,387,000
- Dividend Yield: 2.01%; Annual Dividend Rate: $4.20; Ex-Dividend: 2026-09-09
- Beta: -0.17 (inverse market correlation)
- 52-Week High: $214.78; 52-Week Low: $140.11
- Institutional Ownership: 70.71%
- Average Volume: 1,845,000; Historical Volatility: 25.65%
- Fiscal Year End: 2026-09-01
Revenue growth, profit margins, ROE, debt/equity, and free cash flow are not available in the data (null). Forward PE, PEG, and price/book are also null. The trailing P/E of 63.00 is elevated versus typical industrial/med-tech peers, suggesting a premium valuation. Analyst consensus and target price are null. Fundamentals show a stable dividend and defensive beta, but the high P/E diverges from the sharp technical rally and bullish options sentiment, indicating the move is not clearly supported by disclosed fundamental metrics.
Current Market Position
Current price per indicators: $212.72 (2026-11-05 close). Minute bars show 2026-11-05 open $208.00, high $213.16, low $206.50, close $211.86 early; daily 2026-11-05 close $212.72 with high $214.78. On 2026-11-06 at 14:05, last bar close $212.23, range $212.23–$212.57, low volume (5,745) indicating muted intraday momentum late session.
Price is at the top of the 30-day range (high $214.78, low $175.71) and above all major SMAs.
Technical Analysis
Technical Indicators
SMAs are aligned bullish: 5 > 20 > 50 ($203.06 > $195.43 > $187.58), no bearish crossover. RSI 80.04 indicates overbought momentum. MACD histogram positive (1.08) confirms bullish momentum. Price is above upper Bollinger ($208.82), showing expansion. 30-day range: price near high $214.78, low $175.71.
True Sentiment Analysis (Delta 40-60 Options)
Options flow is Bullish. Call dollar volume $736,550.00 (89.3%) vs put $88,690.00 (10.7%). Call contracts 543, put 207; call trades 10, put trades 2. Total analyzed 534, true sentiment 12 (2.2% filter).
Conviction: Strong directional call buying. Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" with advice to wait for alignment, yet technicals show clear bullish alignment and overbought RSI — divergence is in system interpretation, not raw data.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.